ABSTRACT SARS-CoV-2 serological tests are a subject of intense interest and have the
potential to significantly enhance the diagnostic capability of healthcare services in the …

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) brought
with it rapid development of both molecular and serologic assays for identification of COVID …

Since the outbreak of COVID-19, the world has raced to understand and accurately
diagnose infection caused by SARS-CoV-2. Today, hundreds of commercial antibody tests …

Interest continues to grow regarding the role of serologic assays for the detection of prior
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The US Food …

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome
coronavirus (SARS-CoV-2), continues to be a pandemic. The development of nucleic acid …

Laboratory testing has been a key tool in managing the SARS-CoV-2 global pandemic.
While rapid antigen and PCR testing has proven useful for diagnosing acute SARS-CoV-2 …

Background The role of serologic testing for SARS-CoV-2 has evolved during the pandemic
as seroprevalence in global populations has increased. The Infectious Diseases Society of …

Background: In response to the current COVID-19 pandemic, multiple companies marketed
serological tests. Rigorous, independent and comparative performances of these assays on …

Diagnosis of acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection relies on detection of viral antigens or amplified viral nucleic acids. Serology …

In the last few months, an unprecedented number of laboratory tests for coronavirus disease
2019 (COVID‐19) have been developed at a remarkable speed. With the rapid adoption of …